Clinical Profile

Dr Jayant (Jay) Ravindran is a cardiologist with comprehensive training across leading Australian institutions and a strong commitment to patient-centred care. He currently works as an interventional research fellow at Royal Prince Alfred Hospital and Concord Hospital, where he was awarded Fellowship of the Royal Australasian College of Physicians (FRACP) in 2024.

His clinical interests include coronary artery disease, valvular heart disease, structural heart intervention, heart failure, and preventative cardiology. In parallel with his clinical practice, Dr Ravindran is undertaking a PhD at the University of Sydney focused on improving diagnosis and treatment options for patients with angina and non-obstructive coronary artery disease — research supported by a National Health and Medical Research Council (NHMRC) grant. He remains actively involved in clinical research and has published in peer-reviewed journals and presented at national and international conferences.

Dr Ravindran is dedicated to providing clear, compassionate, and evidence-based care, taking the time to ensure patients fully understand their condition and treatment options. He takes a holistic approach and works closely with patients and referring doctors to achieve the best possible outcomes.

Education & Training

Dr Ravindran completed his Bachelor of Medical Science with High Distinction at the University of New South Wales, followed by his Bachelor of Medicine and Bachelor of Surgery at James Cook University, graduating with distinction. He subsequently completed a Master of Internal Medicine at the University of Sydney.

He completed Basic Physician Training at Royal Prince Alfred Hospital and specialist cardiology training at Concord Hospital, culminating in Fellowship of the Royal Australasian College of Physicians (FRACP) in 2024.

Research

As a cardiologist with a strong interest in coronary disease and patient-centred care, I am currently undertaking a PhD focused on improving the understanding and management of coronary microvascular dysfunction.

My research focuses on improving the diagnosis and treatment of patients who experience chest pain despite having no significant blockages in their coronary arteries—often due to dysfunction of the heart’s smallest blood vessels (the microcirculation). As part of my PhD, I work with advanced techniques performed during coronary angiography to better assess microvascular function, with the aim of identifying more precise and clinically meaningful abnormalities.

A key area of my work is developing a personalised, physiology-guided approach to treatment. This includes investigating how targeted medications can improve blood flow at the microvascular level and, ultimately, reduce symptoms and improve quality of life for patients.

In addition to my research, I am actively involved in teaching and mentoring medical students, junior doctors, and cardiology trainees. I provide hands-on training in advanced cardiac procedures and contribute to educational programs aimed at improving the understanding and management of complex heart conditions. I am committed to translating research into practical, patient-centred care that delivers real-world impact.

Selected Publications

1. Impact of coronary intervention on in-hospital mortality in octogenarians and nonagenarians compared to younger patients with acute coronary syndromes

This study evaluates outcomes following percutaneous coronary intervention in elderly patients presenting with acute coronary syndromes. It demonstrates that, despite higher baseline risk, appropriately selected elderly patients can still benefit from invasive management with acceptable in-hospital outcomes.
PubMed: https://pubmed.ncbi.nlm.nih.gov/40698305/

2. An updated review on therapeutic strategies in coronary microvascular dysfunction


This review summarises current treatment approaches for coronary microvascular dysfunction, a key cause of angina in patients without obstructive coronary disease. It highlights the limited evidence base and the need for physiology-guided, targeted therapeutic strategies.
PubMed: https://pubmed.ncbi.nlm.nih.gov/40068789/

3. Clinical perspectives: Takotsubo cardiomyopathy


This article reviews the clinical features, pathophysiology, and management of Takotsubo cardiomyopathy. It emphasises the importance of distinguishing it from acute coronary syndromes due to its distinct clinical course and management implications.
PubMed: https://pubmed.ncbi.nlm.nih.gov/39248550/

4. Cause-specific mortality in patients hospitalised for myocarditis from 2004 to 2021: a retrospective statewide population-linkage study


This statewide population-linkage study examines long-term cause-specific mortality following hospitalisation for myocarditis. It demonstrates high early cardiovascular mortality with a subsequent shift towards non-cardiovascular causes of death over long-term follow-up.
PubMed: https://pubmed.ncbi.nlm.nih.gov/40565834/

5. Prominent V waves in right heart catheterisation as a marker of left atrial stiffness in pulmonary hypertension


This study evaluates the significance of prominent V waves during right heart catheterisation in patients with pulmonary hypertension. It shows that prominent V waves are associated with increased left atrial stiffness and elevated left-sided filling pressures, reflecting impaired diastolic compliance.
PubMed: https://pubmed.ncbi.nlm.nih.gov/40940045/